financetom
Business
financetom
/
Business
/
Beyond Meat to Expand Product Distribution at Walmart; Beyond Shares Rise Over 50%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Beyond Meat to Expand Product Distribution at Walmart; Beyond Shares Rise Over 50%
Oct 21, 2025 6:51 AM

09:33 AM EDT, 10/21/2025 (MT Newswires) -- Beyond Meat ( BYND ) said Tuesday it will increase the availability of some of its plant-protein products at over 2,000 Walmart ( WMT ) stores in the US.

Financial details were not provided.

Walmart ( WMT ) will also be among the first US retailers to offer the company's Beyond Burger 6-Pack product, Beyond Meat ( BYND ) said.

Beyond Meat ( BYND ) shares were up over 50% in recent early trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Septerna Discontinues Phase 1 Trial of SEP-786 for Hypoparathyroidism; Shares Fall Pre-Bell
Septerna Discontinues Phase 1 Trial of SEP-786 for Hypoparathyroidism; Shares Fall Pre-Bell
Feb 18, 2025
08:44 AM EST, 02/18/2025 (MT Newswires) -- Septerna ( SEPN ) shares were down sharply premarket Tuesday after the company said it has discontinued a phase 1 clinical trial of SEP-786 for the potential treatment of hypoparathyroidism in healthy volunteers. The company said the decision follows two unanticipated severe events of elevated unconjugated bilirubin in a portion of the trial,...
Purple Biotech Moves NT219 Into Phase 2 Trial Aimed at Overcoming Tumor Resistance in Head, Neck Cancer Therapies
Purple Biotech Moves NT219 Into Phase 2 Trial Aimed at Overcoming Tumor Resistance in Head, Neck Cancer Therapies
Feb 18, 2025
08:41 AM EST, 02/18/2025 (MT Newswires) -- Purple Biotech ( PPBT ) said Tuesday it is advancing its drug candidate NT219 into a phase 2 clinical trial aimed at overcoming tumor resistance in therapies for recurring metastatic squamous cell cancer of the head and neck. The study will evaluate the safety and efficacy of NT219 in combination with standard therapies...
Expeditors International of Washington's Q4 Earnings, Revenue Rise
Expeditors International of Washington's Q4 Earnings, Revenue Rise
Feb 18, 2025
08:49 AM EST, 02/18/2025 (MT Newswires) -- Expeditors International of Washington ( EXPD ) reported Q4 earnings Tuesday of $1.68 per diluted share, compared with $1.09 a year earlier. Analysts surveyed by FactSet expected $1.43. Revenue for the quarter ended Dec. 31 was $2.95 billion, compared with $2.28 billion a year earlier. Analysts surveyed by FactSet expected $2.79 billion. Shares...
Espey Mfg. & Electronics Names Kaitlyn O'Neil as Principal Financial Officer
Espey Mfg. & Electronics Names Kaitlyn O'Neil as Principal Financial Officer
Feb 18, 2025
08:44 AM EST, 02/18/2025 (MT Newswires) -- Espey Mfg. & Electronics Corp. ( ESP ) said Tuesday it has named Kaitlyn O'Neil as principal financial officer and treasurer, effective Feb. 15. The appointment comes after the retirement of Katrina Sparano, who served as chief financial officer of the company. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved